Patents by Inventor Joshua Kostera

Joshua Kostera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220411873
    Abstract: The disclosure is directed to kits and methods for amplifying and detecting human papilloma virus (HPV) of genotype 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and/or 68 in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.
    Type: Application
    Filed: June 7, 2022
    Publication date: December 29, 2022
    Inventors: Wesley Grimm, Joshua Kostera, Robert Hillman, Hong Wang, Ning Tang, Shihai Huang, Klara Abravaya
  • Patent number: 11384398
    Abstract: The disclosure is directed to kits and methods for amplifying and detecting human papilloma virus (HPV) of genotype 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and/or 68 in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: July 12, 2022
    Assignee: ABBOTT MOLECULAR INC.
    Inventors: Wesley Grimm, Joshua Kostera, Robert Hillman, Hong Wang, Ning Tang, Shihai Huang, Klara Abravaya
  • Patent number: 11225693
    Abstract: Provided herein are compositions and methods for diagnosing and characterizing tuberculosis infection. In particular, provided herein are compositions and methods for identifying drug resistant tuberculosis.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: January 18, 2022
    Assignee: ABBOTT MOLECULAR INC.
    Inventors: Hong Wang, Gregor W. Leckie, Vihanga Pahalawatta, Klara Abravaya, Joshua Kostera, Ning Tang, Andrea Frank
  • Publication number: 20200199678
    Abstract: The disclosure is directed to kits and methods for amplifying and detecting human papilloma virus (HPV) of genotype 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and/or 68 in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.
    Type: Application
    Filed: December 18, 2019
    Publication date: June 25, 2020
    Inventors: Wesley Grimm, Joshua Kostera, Robert Hillman, Hong Wang, Ning Tang, Shihai Huang, Klara Abravaya
  • Publication number: 20200080135
    Abstract: Provided herein are compositions and methods for diagnosing and characterizing tuberculosis infection. In particular, provided herein are compositions and methods for identifying drug resistant tuberculosis.
    Type: Application
    Filed: November 22, 2019
    Publication date: March 12, 2020
    Inventors: Hong Wang, Gregor W. Leckie, Vihanga Pahalawatta, Klara Abravaya, Joshua Kostera, Ning Tang, Andrea Frank
  • Patent number: 10526664
    Abstract: Provided herein are compositions and methods for diagnosing and characterizing tuberculosis infection. In particular, provided herein are compositions and methods for identifying drug resistant tuberculosis.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: January 7, 2020
    Assignee: Abbott Molecular Inc.
    Inventors: Hong Wang, Gregor W. Leckie, Vihanga Pahalawatta, Klara Abravaya, Joshua Kostera, Ning Tang, Andrea Frank
  • Publication number: 20170044594
    Abstract: Provided herein are compositions and methods for diagnosing and characterizing tuberculosis infection. In particular, provided herein are compositions and methods for identifying drug resistant tuberculosis.
    Type: Application
    Filed: July 13, 2016
    Publication date: February 16, 2017
    Inventors: Hong Wang, Gregor W. Leckie, Vihanga Pahalawatta, Klara Abravaya, Joshua Kostera, Ning Tang, Andrea Frank